John D Young Pfizer Inc (PFE) insider trading activity

John D Young is Group President of PFIZER INC. Currently has a direct ownership of 312,704 shares of PFE, which is worth approximately $9.3 Million. The most recent transaction as insider was on Nov 11, 2021, when has been sold 150,000 shares (Common Stock) at a price of $50.09 per share, resulting in proceeds of $7,513,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 313K

0% 3M change

0% 12M change

Total Value Held $9.3 Million

JOHN D YOUNG Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 11 2021	SELL Open market or private sale	$7,513,500 $50.09 p/Share	150,000 Reduced 32.42%	312,704 Common Stock
May 07 2021	SELL Bona fide gift	-	8,830 Reduced 1.88%	461,761 Common Stock
Feb 27 2021	SELL Payment of exercise price or tax liability	$3,585,902 $34.07 p/Share	105,251 Reduced 18.3%	470,031 Common Stock
Feb 27 2021	BUY Exercise of conversion of derivative security	$2,892,515 $22.35 p/Share	129,419 Added 18.37%	575,282 Common Stock
Feb 25 2021	SELL Payment of exercise price or tax liability	$4,592,391 $34.29 p/Share	133,928 Reduced 23.1%	445,863 Common Stock
Feb 25 2021	BUY Exercise of conversion of derivative security	$3,738,715 $22.89 p/Share	163,334 Added 21.98%	579,791 Common Stock
Dec 29 2020	SELL Payment of exercise price or tax liability	$392,989 $37.05 p/Share	10,607 Reduced 2.49%	415,947 Common Stock
Apr 29 2020	SELL Bona fide gift	-	7,910 Reduced 1.84%	421,072 Common Stock
Feb 28 2020	SELL Payment of exercise price or tax liability	$2,645,773 $34.93 p/Share	75,745 Reduced 15.02%	428,682 Common Stock
Feb 28 2020	BUY Exercise of conversion of derivative security	$2,751,999 $27.37 p/Share	100,548 Added 16.62%	504,427 Common Stock
Feb 26 2020	SELL Payment of exercise price or tax liability	$5,149,499 $35.41 p/Share	145,425 Reduced 26.47%	403,879 Common Stock
Feb 26 2020	BUY Grant, award, or other acquisition	-	45,566 Added 7.66%	549,304 Common Stock
Feb 26 2020	BUY Exercise of conversion of derivative security	$5,013,060 $34.59 p/Share	144,928 Added 22.34%	503,738 Common Stock
Dec 29 2019	SELL Payment of exercise price or tax liability	$380,460 $39.32 p/Share	9,676 Reduced 2.63%	358,149 Common Stock
Dec 16 2019	SELL Bona fide gift	-	1,280 Reduced 0.35%	367,825 Common Stock
Feb 27 2019	SELL Payment of exercise price or tax liability	$7,320,029 $42.72 p/Share	171,349 Reduced 31.84%	366,757 Common Stock
Feb 27 2019	BUY Grant, award, or other acquisition	-	96,183 Added 15.16%	538,106 Common Stock
Feb 27 2019	BUY Exercise of conversion of derivative security	$4,975,474 $32.23 p/Share	154,374 Added 25.89%	441,923 Common Stock
Feb 23 2019	SELL Payment of exercise price or tax liability	$1,054,555 $42.43 p/Share	24,854 Reduced 7.96%	287,549 Common Stock
Feb 23 2019	BUY Exercise of conversion of derivative security	$919,516 $21.03 p/Share	43,724 Added 12.28%	312,403 Common Stock

Also insider at

JCI

Johnson Controls International plc Industrials

Director

ARVN

ARVINAS, INC. Healthcare

Director

JDY

John D Young

Group President

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PFE shares.

Notify only if

Value

Insider Trading

Get notified when an Pfizer Inc insider buys or sells PFE shares.

Notify only if

Operation

Value

Type

News

Receive news related to PFIZER INC

Track Activities on PFE

Account